Rajasekharan Somasundaram Selected Research

ErbB Receptors (EGF Receptor)

11/2004

Immune responses of breast cancer patients to mutated epidermal growth factor receptor (EGF-RvIII, Delta EGF-R, and de2-7 EGF-R).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rajasekharan Somasundaram Research Topics

Disease

37	Melanoma (Melanoma, Malignant) 01/2022 - 03/2003
35	Neoplasms (Cancer) 01/2022 - 04/2002
6	Colorectal Neoplasms (Colorectal Cancer) 09/2010 - 04/2002
4	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2009
4	Carcinoma (Carcinomatosis) 09/2010 - 04/2003
3	Breast Neoplasms (Breast Cancer) 01/2022 - 11/2004
3	Glioma (Gliomas) 04/2007 - 04/2003
2	Inflammation (Inflammations) 01/2019 - 01/2013
1	Triple Negative Breast Neoplasms 01/2022
1	Bacterial Infections (Bacterial Infection) 01/2021
1	Experimental Melanoma 02/2016
1	Disease Progression 01/2014
1	Squamous Cell Carcinoma of Head and Neck 12/2013
1	Rectal Neoplasms (Rectal Cancer) 09/2010
1	Neuroectodermal Tumors (Neuroectodermal Tumor) 04/2009
1	Neuroblastoma 04/2009
1	Glioblastoma (Glioblastoma Multiforme) 04/2009
1	Ulcerative Colitis 05/2006

Drug/Important Bio-Agent (IBA)

13	AntigensIBA 02/2016 - 04/2002
10	AntibodiesIBA 03/2016 - 04/2002
8	ChemokinesIBA 12/2021 - 05/2005
8	VaccinesIBA 02/2016 - 04/2002
7	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2003
5	Peptides (Polypeptides)IBA 02/2016 - 03/2006
5	Chemokine ReceptorsIBA 04/2009 - 05/2005
4	CollagenIBA 01/2022 - 05/2005
4	LigandsIBA 04/2014 - 05/2005
3	Immune Checkpoint InhibitorsIBA 01/2021 - 03/2016
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2015
3	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2018 - 12/2010
3	CytokinesIBA 04/2009 - 04/2003
3	Monoclonal AntibodiesIBA 07/2008 - 04/2002
2	Immunoglobulin G (IgG)IBA 01/2022 - 07/2008
2	Programmed Cell Death 1 ReceptorIBA 12/2021 - 03/2016
2	IpilimumabIBA 01/2015 - 03/2013
2	Conditioned Culture MediaIBA 04/2014 - 07/2012
2	Rituximab (Mabthera)FDA Link 11/2012 - 05/2012
2	GD2 gangliosideIBA 07/2008 - 03/2003
2	Epithelial Cell Adhesion MoleculeIBA 05/2006 - 04/2002
2	HLA Antigens (Human Leukocyte Antigens)IBA 03/2006 - 11/2005
2	Anti-Idiotypic AntibodiesIBA 03/2003 - 04/2002
1	Glycogen Synthase (Synthase I)IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	Therapeutic UsesIBA 01/2022
1	Sunitinib (Sutent)FDA Link 12/2021
1	indolepropanol phosphate (IPP)IBA 12/2021
1	resiquimodIBA 12/2021
1	Imatinib Mesylate (Gleevec)FDA Link 12/2021
1	RNA (Ribonucleic Acid)IBA 12/2021
1	ProdrugsIBA 01/2021
1	Immunologic Factors (Immunomodulators)IBA 01/2021
1	NucleosidesIBA 10/2018
1	Telomerase (Telomerase Reverse Transcriptase)IBA 10/2018
1	alpha-2'-deoxythioguanosineIBA 10/2018
1	Drug CombinationsIBA 01/2018
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2017
1	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2017
1	InterferonsIBA 02/2016
1	OvalbuminIBA 02/2016
1	HLA-B57 antigenIBA 01/2015
1	NivolumabIBA 01/2015
1	Cancer VaccinesIBA 01/2015
1	Indomethacin (Indometacin)FDA LinkGeneric 05/2014
1	Chemotactic FactorsIBA 04/2014
1	Macrophage Colony-Stimulating FactorIBA 04/2014
1	Matrix Metalloproteinases (MMPs)IBA 07/2012
1	Glycoproteins (Glycoprotein)IBA 07/2012
1	IgA receptor (protein B)IBA 07/2012
1	Indicators and Reagents (Reagents)IBA 01/2012
1	CCR2 ReceptorsIBA 03/2011
1	Proto-Oncogene Proteins A-rafIBA 12/2010
1	Protein Isoforms (Isoforms)IBA 12/2010
1	NucleophosminIBA 09/2010
1	HLA-A1 Antigen (HLA A1 Antigen)IBA 09/2010
1	Immunoglobulin M (IgM)IBA 07/2008
1	keyhole-limpet hemocyanin (keyhole limpet hemocyanin)IBA 07/2008
1	saponin QA-21V1 (QS21)IBA 07/2008
1	rat ribosomal protein L8IBA 04/2007
1	Histocompatibility Antigens Class IIIBA 04/2007
1	Neoplasm Antigens (Tumor Antigens)IBA 03/2007
1	Chemokine CXCL11IBA 03/2007
1	Carbohydrate Tumor-Associated Antigens (Antigens, Tumor-Associated Carbohydrate)IBA 05/2006
1	HLA-A2 Antigen (HLA A2 Antigen)IBA 03/2006
1	CCR ReceptorsIBA 02/2006
1	CC ChemokinesIBA 02/2006
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 11/2005
1	CXC ChemokinesIBA 05/2005
1	Chemokine CXCL12IBA 05/2005
1	Collagen Type I (Type I Collagen)IBA 05/2005
1	Epidermal Growth Factor (EGF)IBA 11/2004
1	ErbB Receptors (EGF Receptor)IBA 11/2004
1	Interleukin-2 (IL2)IBA 09/2003

Therapy/Procedure

26	Therapeutics 01/2022 - 04/2003
5	Immunotherapy 12/2021 - 07/2008
2	Drug Therapy (Chemotherapy) 03/2016 - 05/2012
1	Salvage Therapy 01/2018
1	Aftercare (After-Treatment) 02/2016
1	Biological Therapy 03/2013
1	Radiotherapy 05/2012